Vera Therapeutics, Inc. (VERA) Discusses Final Efficacy Results of ORIGIN Phase III Trial of Atacicept in IgA Nephropathy October 22, 2026 4:30 PM...
CryptoAlerta — análise de criptomoedas e mercado em tempo real